current treatment options for dlbcl besides r-chop chemotherapy
Published 4 years ago • 1.9K plays • Length 1:12Download video MP4
Download video MP3
Similar videos
-
20:48
current upfront management of dlbcl
-
4:39
treatment alternatives to chemotherapy in r/r dlbcl
-
2:41
treatment options for relapsed-refractory dlbcl
-
6:43
current treatment approach to relapsed/refractory dlbcl
-
1:24
unmet needs remain in the diffuse large b-cell lymphoma treatment paradigm
-
2:42
progression after r-chop: what next?
-
1:26
can we improve on r-chop for the frontline treatment of dlbcl?
-
58:24
update on diffuse large b-cell lymphoma | lrf webinars
-
4:05
selecting therapy for relapsed-refractory dlbcl
-
16:21
should r-chop remain the standard of care for dlbcl?
-
4:46
treatment of r/r dlbcl: cd19-targeted monoclonal antibodies
-
2:16
what factors should be considered when choosing between novel treatment options for r/r dlbcl?
-
3:37
how does your dlbcl subtype impact your treatment options?
-
2:54
selecting therapy for relapsed-refractory dlbcl
-
15:16
debate: how should patients with abc type dlbcl be treated today? - r-chop
-
0:42
targeted therapies for dlbcl treatment
-
4:01
first- and second-line treatment in dlbcl
-
2:57
future directions for r/r dlbcl
-
2:03
dr. poeschel on 6 versus 4 cycles of r-chop in frontline dlbcl